170 likes | 557 Vues
Immunotherapy for Head and Neck Cancer?. Thomas K. Hoffmann. Dept. of Otorhinolaryngology. ADCC (NK-cell). Immune Cell Infiltration. Anti-EGFR-Antibody. • Targeted Therapy • Signaling ↓ • Immunotherapy?. HNSCC. + Immune Cells. CD3/ 14 /16. Immune Cell Infiltration. Native.
E N D
Immunotherapy for Head and Neck Cancer? Thomas K. Hoffmann Dept. of Otorhinolaryngology
ADCC (NK-cell) Immune Cell Infiltration Anti-EGFR-Antibody • Targeted Therapy • Signaling ↓ • Immunotherapy? HNSCC
+ Immune Cells CD3/14/16 Immune Cell Infiltration Native + Immune Cells + anti-EGFR Ab Array+Functional Assays: MCP-1
Active Vaccine Immunotherapy for Head&Neck Cancer Antibody Passive Immunotherapy
Vaccine • Variolae Vaccinae Edward Jenner (1749-1823) • Active Immunisisation • Tumor antigen as vaccine • Induction of T-cell response
Peptides Protein DC Antigen presenting cell p53 Lysate/Apo HPV16 EGFR RNA/DNA Induction of T-cell response Tumor cell T-cells Antigen
Clinical Pilot Studies • DC+APO – closed – technically difficult • DC+p53 Peptides – open • DC+DNA – open • HNSCC+Newcastle Disease Virus – closed
Immunotherapy for Head and Neck Cancer? • Anti-EGFR-Ab – passive IT • Vaccination – active IT • Combination – fighting MRD • Induction of tumor-specific memory